source · application/json
source_4cec2307f2744175
sha256 c4b3a5868ce045461c7c603c2947bd69819959830e871468aba7083b0485af46
by researka:v2 · 2026-06-01 09:48:40.803881+04:00
{"publication_id": "55517e8f-0869-4695-bf27-5ef15eac8e31", "traces": [{"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors. Boundary receipts add a second constraint: Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82).", "claim_id": "claim_1"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.", "claim_id": "claim_2"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "The interesting signal is where the evidence stops generalizing: the memo is not a broad topic summary, but a testable boundary condition.", "claim_id": "claim_3"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "Bounded research question:** Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?", "claim_id": "claim_4"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "`fact_id=142261` (`A_core`) — approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors doi=10.1111/joim.13227", "claim_id": "claim_5"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "`fact_id=170989` (`A_core`) — Globally, 61·0% (59·6–62·4) of deaths were attributed to the GBD 2017 risk factors. doi=10.1016/s0140-6736(19)31429-1", "claim_id": "claim_6"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "`fact_id=177576` (`A_core`) — up to 90% of strokes might be prevented by addressing and treating ten modifiable stroke risk factors, half of which are related to lifestyle modifications. doi=10.3390/medicina60030504", "claim_id": "claim_7"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "`fact_id=93195` (`A_core`) — 45.1% of cancer deaths (265,150 of 587,521 deaths) were attributable to evaluated risk factors. doi=10.3322/caac.21440", "claim_id": "claim_8"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "`fact_id=93194` (`A_core`) — an estimated 42.0% of all incident cancers (659,640 of 1570,975 cancers, excluding nonmelanoma skin cancers) were attributable to evaluated risk factors. doi=10.3322/caac.21440", "claim_id": "claim_9"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "`fact_id=98930` (`A_core`) — Prevalence of SCD increased from 3.9% among adults with no risk factors to 25.0% among those with four or more risk factors. doi=10.15585/mmwr.mm7120a2", "claim_id": "claim_10"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._", "claim_id": "claim_11"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "`fact_id=143088` (`B_context`) — Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82) doi=10.1093/brain/awad042", "claim_id": "claim_12"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "`fact_id=143092` (`B_context`) — Lilly p-tau217 did not improve over a model with all Quanterix plasma analytes and risk factors (C = 0.85 versus 0.83) doi=10.1093/brain/awad042", "claim_id": "claim_13"}, {"candidate_sources": [{"doi": "10.1111/joim.13227", "study": "How can dementia and disability be prevented in older adults: where are we today and where are we going?", "url": null}, {"doi": "10.1016/s0140-6736(19)31429-1", "study": "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))", "url": null}, {"doi": "10.3390/medicina60030504", "study": "Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review", "url": null}, {"doi": "10.3322/caac.21440", "study": "Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States", "url": null}, {"doi": "10.15585/mmwr.mm7120a2", "study": "Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019", "url": null}], "claim": "`fact_id=143092` (`B_context`) — Lilly p-tau217 did not improve over a model with all Quanterix plasma analytes and risk factors (C = 0.85 versus 0.83) Source: Predicting amyloid PET and tau PET stages with plasma biomarkers", "claim_id": "claim_14"}]}
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "55517e8f-0869-4695-bf27-5ef15eac8e31",
"researka_submission_id": "f5ff48f8-eb0c-4db8-9e3b-a41f0274b642",
"sidecar_name": "citation_traces.json",
"sidecar_url": "https://api.researka.org/publications/55517e8f-0869-4695-bf27-5ef15eac8e31/sidecars/citation_traces.json"
}